Thus, our study reveals a new cooperative regulatory mechanism of YAP/TEAD4 transcriptional activity by HHEX, highlighting the therapeutic potential of targeting the HHEX-TEAD4 interaction in CRC. This evidence concerns the gene TEAD4 and colorectal carcinoma.